Entrada Therapeutics
TRDA
#9077
Rank
C$0.24 B
Marketcap
C$6.24
Share price
-6.25%
Change (1 day)
-56.25%
Change (1 year)

EPS for Entrada Therapeutics (TRDA)

EPS in 2026 (TTM): C-$5.38

According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is C-$5.51. In 2025 the company made an earnings per share (EPS) of C-$4.96 a decrease over its 2024 EPS that were of C$2.85.

EPS history for Entrada Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$5.388.46%
2025C-$4.96-273.87%
2024C$2.85
2022C-$4.3331.74%
2021C-$3.29